BPC-157
Repair peptide for stalled tendons, gut lining, and slow healing — not a painkiller.
Tissue repair / gastric-derived pentadecapeptide
Research / compounded in most jurisdictions. Not FDA-approved as a finished drug for injury or gut indications.
15-amino-acid fragment from human gastric juice (Body Protection Compound). Acid-stable enough that oral use is discussed for gut applications. Short plasma half-life (<30 minutes) with longer tissue signaling (VEGF / angiogenesis, growth-factor and nitric-oxide pathways, cell migration).
Common-practice ranges — not a personal dose
Quick-reference (Vol 1 Ch.1 arsenal)
250–500 mcg twice daily for gut, tendon, ligament, and muscle repair.
VOL1 · Chapter 1 · p.12
Systemic SC / IM (Vol 1 Ch.4)
Standard 200–500 µg daily, split into 1–2 injections. Duration 2–4 weeks acute, 6–8 weeks chronic. Rotate abdomen and thighs. Start 200–250 µg.
VOL1 · Chapter 4 · p.45–46
Localized peri-lesional (Vol 1 Ch.4)
100–200 µg per injection, 2–3 times weekly, 4–6 weeks, into or around target tissue.
VOL1 · Chapter 4 · p.45
Oral GI focus (Vol 1 Ch.4)
500 µg to 2 mg daily on an empty stomach, 4–8 weeks, capsule or oral solution (higher because of partial absorption).
VOL1 · Chapter 4 · p.46
Practical daily range used in Vol 2 protocols
250–500 mcg/day SC once daily or divided BID. Localized injury 250–500 mcg/day near (not into) tissue. GI: 250–500 mcg/day oral or SC. Clinical note: going above 500–750 mcg/day rarely helps and may rebound inflammation.
VOL2 · Chapter 4 · p.25–26
Cycle / washout. Vol 2: typical 4–6 weeks, up to 8 weeks chronic, washout 2–4 weeks. Re-cycle only if structural recovery is incomplete. If plateaued, do not escalate dose — reassess rehab, inflammation, or stacking.
- First-line painkiller instead of rehab
- Cosmetic or vague wellness without a repair target
- Active malignancy (theoretical angiogenesis concern)
- Pregnancy / lactation (no safety data)
Sources: Vol 1 Ch.1 pp.12–13 · Vol 1 Ch.4 pp.43–55 · Vol 2 Ch.4 pp.21–28